Brief: Guardant Health Q1 Adjusted EPS USD -0.49 Vs. IBES Estimate USD -0.81
30/04/2025 21:05
Apr 30 (Reuters) - Guardant Health Q1 revenue USD 203.5 million vs. IBES estimate USD 190.1 million. Q1 EPS USD -0.77 Q1 adjusted net income USD -61.1 million vs. IBES estimate USD -94.3 million Q1 adjusted EBITDA USD -58.5 million vs. IBES estimate USD -66.5 million outlook FY revenue USD 880-890 million
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment